Related Experiment Videos

Limitations of immunofluorescence tests in the diagnosis of infectious mononucleosis

Insights

Diagnosing infectious mononucleosis (IM) involves comparing heterophil agglutinins (HA) and Epstein-Barr virus (EBV) antibodies. Specific EBV antibody tests are useful for borderline cases, while HA tests show varying sensitivity and false-positive rates.

Area of Science:

  • Immunology
  • Virology
  • Clinical Diagnostics

Background:

  • Infectious mononucleosis (IM) diagnosis relies on heterophil agglutinins (HA) and Epstein-Barr virus (EBV) antibodies.
  • Assessing the diagnostic utility of different HA tests and EBV antibody detection is crucial for accurate IM diagnosis.

Purpose of the Study:

  • To compare the diagnostic value of heterophil agglutinins (HA) and specific EBV antibodies in infectious mononucleosis (IM).
  • To evaluate the sensitivity and specificity of various HA tests (sheep cell, horse cell, slide tests) and their comparison with EBV antibody detection.

Main Methods:

  • Analyzed sera from 108 IM cases and 280 controls using sheep cell microtitre, horse cell microtitre, and slide tests for HA.
  • Detected Epstein-Barr virus viral capsid antigen (EBV-VCA) antibodies in cases and controls.
  • Investigated the persistence of HA in a subset of individuals.

Main Results:

  • Horse cell microtitre and Monospot tests demonstrated higher sensitivity for IM diagnosis compared to sheep cell microtitre and Monotest.
  • False-negative HA results were observed with sheep cell tests, while horse cell tests showed more false-positives.
  • Virtually all IM cases possessed EBV-VCA antibodies, contrasting with only half of the control group.

Conclusions:

  • Horse cell microtitre and Monospot tests are more sensitive but yield more false-positives than sheep cell tests for IM diagnosis.
  • Specific EBV-IgM and EBV-EA antibody tests are valuable for diagnosing selected borderline IM cases.
  • The long-lasting nature of HA may lead to misinterpretation of false-positives in unrecognized past infections.

Related Concept Videos